These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22555943)

  • 1. Initial strategy of revascularization versus optimal medical therapy for improving outcomes in ischemic heart disease: a review of the literature.
    Songco AV; Brener SJ
    Curr Cardiol Rep; 2012 Aug; 14(4):397-407. PubMed ID: 22555943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
    ; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
    Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design.
    Bangalore S; Maron DJ; Fleg JL; O'Brien SM; Herzog CA; Stone GW; Mark DB; Spertus JA; Alexander KP; Sidhu MS; Chertow GM; Boden WE; Hochman JS;
    Am Heart J; 2018 Nov; 205():42-52. PubMed ID: 30172098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservative versus invasive stable ischemic heart disease management strategies: what do we plan to learn from the ISCHEMIA trial?
    Cheng-Torres KA; Desai KP; Sidhu MS; Maron DJ; Boden WE
    Future Cardiol; 2016 Jan; 12(1):35-44. PubMed ID: 26696561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical therapy versus coronary angioplasty in stable coronary artery disease: a critical review of the literature.
    Blumenthal RS; Cohn G; Schulman SP
    J Am Coll Cardiol; 2000 Sep; 36(3):668-73. PubMed ID: 10987582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies in stable ischemic heart disease: lessons from the COURAGE and BARI-2D trials.
    Fernandez SF; Boden WE
    Curr Atheroscler Rep; 2010 Nov; 12(6):423-31. PubMed ID: 20845088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization.
    Simoons ML; Windecker S
    Eur Heart J; 2010 Mar; 31(5):530-41. PubMed ID: 20106842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriate therapy for patients with stable ischemic heart disease: a review of literature and the implication of the International Study of Comparative Effectiveness with Medical and Invasive Approaches trial.
    Guo MH; Nantsios A; Ruel M
    Curr Opin Cardiol; 2020 Nov; 35(6):658-663. PubMed ID: 32941193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.
    Stone GW; Hochman JS; Williams DO; Boden WE; Ferguson TB; Harrington RA; Maron DJ
    J Am Coll Cardiol; 2016 Jan; 67(1):81-99. PubMed ID: 26616030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. The ACIP Investigators.
    Rogers WJ; Bourassa MG; Andrews TC; Bertolet BD; Blumenthal RS; Chaitman BR; Forman SA; Geller NL; Goldberg AD; Habib GB
    J Am Coll Cardiol; 1995 Sep; 26(3):594-605. PubMed ID: 7642848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revascularization therapy for coronary artery disease. Coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty.
    Wilson JM; Ferguson JJ
    Tex Heart Inst J; 1995; 22(2):145-61. PubMed ID: 7647598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of ISCHEMIA in stable ischemic heart disease.
    Spilias N; Zorach B; Denby K; Ellis S
    Cleve Clin J Med; 2020 Jun; 87(7):401-409. PubMed ID: 32636193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic outcomes of treatment strategies for type 2 diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
    Hlatky MA; Boothroyd DB; Melsop KA; Kennedy L; Rihal C; Rogers WJ; Venkitachalam L; Brooks MM;
    Circulation; 2009 Dec; 120(25):2550-8. PubMed ID: 19920002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Implications of the ISCHEMIA Trial: Invasive vs Conservative Approach in Stable Coronary Disease.
    Choudhary J; Chiu S; Bhugra P; Bikdeli B; Supariwala A; Jauhar R; Chatterjee S
    Curr Cardiol Rep; 2021 Mar; 23(5):43. PubMed ID: 33704597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revascularization vs. Medical Therapy in Stable Ischemic Heart Disease.
    Weiss S; Weintraub W
    Prog Cardiovasc Dis; 2015; 58(3):299-305. PubMed ID: 26206111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial.
    Velazquez EJ; Lee KL; O'Connor CM; Oh JK; Bonow RO; Pohost GM; Feldman AM; Mark DB; Panza JA; Sopko G; Rouleau JL; Jones RH;
    J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1540-7. PubMed ID: 18023680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic Cardiac Ischemia Pilot (ACIP) study: effects of coronary angioplasty and coronary artery bypass graft surgery on recurrent angina and ischemia. The ACIP investigators.
    Bourassa MG; Pepine CJ; Forman SA; Rogers WJ; Dyrda I; Stone PH; Chaitman BR; Sharaf B; Mahmarian J; Davies RF
    J Am Coll Cardiol; 1995 Sep; 26(3):606-14. PubMed ID: 7642849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coronary revascularization versus optimal medical therapy in elderly patients with stable multivessel disease].
    Bogachev AA; Kozlov KL; Oleksiuk IB
    Adv Gerontol; 2011; 24(4):650-7. PubMed ID: 22550874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of the Landmark ISCHEMIA Trial on the Initial Management of High-Risk Patients with Stable Ischemic Heart Disease.
    Vafaei P; Naderi S; Ambrosy AP; Slade JJ
    Curr Atheroscler Rep; 2021 Sep; 23(11):70. PubMed ID: 34468881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
    Zhang Z; Jones P; Weintraub WS; Mancini GBJ; Sedlis S; Maron DJ; Teo K; Hartigan P; Kostuk W; Berman D; Boden WE; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003971. PubMed ID: 29752388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.